Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer

Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer

<p>Abstract</p> <p>Background</p> <p>The clinical implication of Ras/Raf/ERK pathway activity in breast cancer tissue and its association with response to chemotherapy is controversial. We aimed to explore the value of p90RSK phosphorylation, a downstram molecule of the...

Bibliografski detalji
Glavni autori:	Moon Hyeong-Gon, Yi Jae, Kim Hee, Lee Hea, Lee Kyung-Min, Yi Minju, Ahn Sookyung, Shin Hee-Chul, Ju Ji-hyun, Shin Incheol, Han Wonshik, Noh Dong-Young
Format:	Članak
Jezik:	English
Izdano:	BMC 2012-12-01
Serija:	BMC Cancer
Teme:	Breast cancer P90RSK Chemotherapy Predictive marker ERK Estrogen receptor
Online pristup:	http://www.biomedcentral.com/1471-2407/12/585

Slični predmeti

RSK2 and ERα comrades-in-arms in homeostasis and transformation
od: Katarzyna A. Ludwik, i dr.
Izdano: (2020-11-01)

Identifying requirements for RSK2 specific inhibitors
od: Eric B. Wright, i dr.
Izdano: (2021-01-01)

Radiation therapy induces immunosenescence mediated by p90RSK
od: Masaki Imanishi, i dr.
Izdano: (2022-11-01)

mTORC2 Is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation
od: Po-Chien Chou, i dr.
Izdano: (2020-06-01)

Artemether confers neuroprotection on cerebral ischemic injury through stimulation of the Erk1/2-P90rsk-CREB signaling pathway
od: Shuai Li, i dr.
Izdano: (2021-10-01)

p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer
od: Abdulkader Yassin-Kassab, i dr.
Izdano: (2024-02-01)

RSK Isoforms in Acute Myeloid Leukemia
od: Minyoung Youn, i dr.
Izdano: (2021-06-01)

Corrigendum: p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway
od: Rei J. Abe, i dr.
Izdano: (2021-02-01)

Therapeutic targeting of p90 ribosomal S6 kinase
od: Eric B. Wright, i dr.
Izdano: (2023-12-01)

Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer
od: Immacolata Maietta, i dr.
Izdano: (2024-09-01)

Punicalagin as a novel selective aryl hydrocarbon receptor (AhR) modulator upregulates AhR expression through the PDK1/p90RSK/AP-1 pathway to promote the anti-inflammatory response and bactericidal activity of macrophages
od: Weihong Dai, i dr.
Izdano: (2024-10-01)

p90RSK2, a new MLCK mediates contractility in myosin light chain kinase null smooth muscle
od: Jaspreet Kalra, i dr.
Izdano: (2023-09-01)

RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer
od: Won Seok Yang, i dr.
Izdano: (2023-01-01)

Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin
od: Rasmussen MK, i dr.
Izdano: (2017-12-01)

Ginsenoside Rh1 Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Proliferation through Suppression of the ROS-Mediated ERK1/2/p90RSK/KLF4 Signaling Pathway
od: Diem Thi Ngoc Huynh, i dr.
Izdano: (2022-03-01)

Substituted pteridinones, pyrimidines, pyrrolopyrimidines, and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors: Pharmacophore modeling data
od: Becka M. Warfield, i dr.
Izdano: (2021-10-01)

Updating mRNA variants of the human RSK4 gene and their expression in different stressed situations
od: Zhenwei Qin, i dr.
Izdano: (2024-04-01)

CD147 mediates epidermal malignant transformation through the RSK2/AP-1 pathway
od: Xu Zhang, i dr.
Izdano: (2022-08-01)

Raltitrexed regulates proliferation and apoptosis of HGC-27 cells by upregulating RSK4
od: Cong Hu, i dr.
Izdano: (2022-08-01)

Application of genetic algorithm - multiple linear regressions to predict the activity of RSK inhibitors
od: Avval Zhila Mohajeri, i dr.
Izdano: (2015-01-01)

Matriptase activation of Gq drives epithelial disruption and inflammation via RSK and DUOX
od: Jiajia Ma, i dr.
Izdano: (2021-06-01)

RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study
od: Alejandro M. S. Mayer, i dr.
Izdano: (2021-09-01)

Drosophila RSK Influences the Pace of the Circadian Clock by Negative Regulation of Protein Kinase Shaggy Activity
od: Katherina Beck, i dr.
Izdano: (2018-04-01)

Analgesic
od: Bian Juhua, i dr.
Izdano: (2016-05-01)

RSK2 promotes melanoma cell proliferation and vemurafenib resistance via upregulating cyclin D1
od: Hai-Zhou Wu, i dr.
Izdano: (2022-09-01)

Effect of RSK4 on biological characteristics of colorectal cancer
od: Qingqing Ye, i dr.
Izdano: (2018-12-01)

L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness
od: Raquel A. C. Machado, i dr.
Izdano: (2021-02-01)

RSK4 promotes the metastasis of clear cell renal cell carcinoma by activating RUNX1-mediated angiogenesis
od: Jing Ma, i dr.
Izdano: (2025-12-01)

EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling
od: Markus Linder, i dr.
Izdano: (2018-10-01)

Association Between RSK2 and Clinical Indexes of Primary Breast Cancer: A Meta-Analysis Based on mRNA Microarray Data
od: Kun Zheng, i dr.
Izdano: (2021-11-01)

Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4B
od: Wenwen Wu, i dr.
Izdano: (2024-10-01)

Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma
od: Yayoi Matsumura‐Kimoto, i dr.
Izdano: (2020-07-01)

The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
od: Tao H, i dr.
Izdano: (2019-04-01)

Animal Models for Coffin-Lowry Syndrome: RSK2 and Nervous System Dysfunction
od: Matthias Fischer, i dr.
Izdano: (2018-05-01)

Loss of the Coffin-Lowry syndrome-associated gene RSK2 alters ERK activity, synaptic function and axonal transport in Drosophila motoneurons
od: Katherina Beck, i dr.
Izdano: (2015-11-01)

Correlation of TRAF4 and RSK4 Protein Expression Levels in Gastric Cancer Tissues with Recurrence After Laparoscopic Radical Resection
od: WU Ling, i dr.
Izdano: (2023-02-01)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
od: Jing Ma, i dr.
Izdano: (2020-03-01)

Marine-Based Candidates as Potential RSK1 Inhibitors: A Computational Study
od: Mousa AlTarabeen, i dr.
Izdano: (2022-12-01)

Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication
od: Todd M. Bell, i dr.
Izdano: (2018-04-01)

DockCADD: A streamlined in silico pipeline for the identification of potent ribosomal S6 Kinase 2 (RSK2) inhibitors
od: El Mehdi Karim, i dr.
Izdano: (2025-03-01)